{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:37:00Z","timestamp":1792089420455,"version":"4.4.0"},"reference-count":114,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["310030_185318\/1"],"award-info":[{"award-number":["310030_185318\/1"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"EU Framework Programme for Research and Innovation Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["812915"],"award-info":[{"award-number":["812915"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.omtn.2026.102852","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:13:48Z","timestamp":1770077628000},"page":"102852","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Non-cytolytic re-engineering of a viral vaccine vector enables durable effector-memory T cell immunity by reinforcing type I IFN induction"],"prefix":"10.1016","volume":"37","author":[{"given":"Matias","family":"Ciancaglini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Avanthay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Friederike","family":"Marx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago","family":"Abreu-Mota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Finozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Fixemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Geier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Burri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilena","family":"Vincenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Kreuzfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doron","family":"Merkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1594-3189","authenticated-orcid":false,"given":"Daniel D.","family":"Pinschewer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2026.102852_bib1","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nm.f.1774","article-title":"CD8+ T cell efficacy in vaccination and disease","volume":"14","author":"Appay","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2026.102852_bib2","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.4049\/jimmunol.1402605","article-title":"CD8+ T cells complement antibodies in protecting against yellow fever virus","volume":"194","author":"Bassi","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.omtn.2026.102852_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007748","article-title":"CD8+ T cells retain protective functions despite sustained inhibitory receptor expression during Epstein-Barr virus infection in vivo","volume":"15","author":"Chatterjee","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.omtn.2026.102852_bib4","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/nm.2447","article-title":"CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates","volume":"17","author":"Sullivan","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2026.102852_bib5","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1038\/s41467-023-37050-6","article-title":"Rapid protection induced by a single-shot Lassa vaccine in male cynomolgus monkeys","volume":"14","author":"Mateo","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.102852_bib6","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1126\/science.283.5408.1748","article-title":"HLA and HIV-1: heterozygote advantage and B\u221735-Cw\u221704 disadvantage","volume":"283","author":"Carrington","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.omtn.2026.102852_bib7","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/nm0297-212","article-title":"Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS","volume":"3","author":"Goulder","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2026.102852_bib8","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41586-020-03041-6","article-title":"Correlates of protection against SARS-CoV-2 in rhesus macaques","volume":"590","author":"McMahan","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.102852_bib9","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.cell.2022.03.024","article-title":"Vaccine protection against the SARS-CoV-2 Omicron variant in macaques","volume":"185","author":"Chandrashekar","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2026.102852_bib10","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1056\/NEJMc2115596","article-title":"Differential Kinetics of Immune Responses Elicited by Covid-19 Vaccines","volume":"385","author":"Collier","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtn.2026.102852_bib11","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1038\/s41467-022-31721-6","article-title":"A third vaccination with a single T cell epitope confers protection in a murine model of SARS-CoV-2 infection","volume":"13","author":"Pardieck","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.102852_bib12","article-title":"Neutralizing-antibody-independent SARS-CoV-2 control correlated with intranasal-vaccine-induced CD8(+) T cell responses","volume":"3","author":"Ishii","year":"2022","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.omtn.2026.102852_bib13","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41590-024-01787-z","article-title":"Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination","volume":"25","author":"Fumagalli","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.omtn.2026.102852_bib14","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41586-021-04388-0","article-title":"Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2","volume":"602","author":"Liu","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.102852_bib15","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41586-021-03681-2","article-title":"Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans","volume":"596","author":"Alter","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.102852_bib16","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-022-04465-y","article-title":"Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron","volume":"603","author":"Liu","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.102852_bib17","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41586-023-06937-1","article-title":"Prevention of respiratory virus transmission by resident memory CD8(+) T cells","volume":"626","author":"Uddback","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.102852_bib18","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.celrep.2015.10.034","article-title":"Adenoviral Vector Vaccination Induces a Conserved Program of CD8(+) T Cell Memory Differentiation in Mouse and Man","volume":"13","author":"Bolinger","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.omtn.2026.102852_bib19","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/nm.2104","article-title":"Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity","volume":"16","author":"Flatz","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2026.102852_bib20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41392-023-01408-5","article-title":"Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.omtn.2026.102852_bib21","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.virol.2006.10.026","article-title":"Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primates","volume":"360","author":"Johnson","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.omtn.2026.102852_bib22","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/S1473-3099(15)00154-1","article-title":"The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1\/2 trial","volume":"15","author":"Huttner","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.omtn.2026.102852_bib23","doi-asserted-by":"crossref","first-page":"13231","DOI":"10.1128\/JVI.79.21.13231-13238.2005","article-title":"A single-cycle vaccine vector based on vesicular stomatitis virus can induce immune responses comparable to those generated by a replication-competent vector","volume":"79","author":"Publicover","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2026.102852_bib24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.virol.2008.03.002","article-title":"SARS vaccine based on a replication-defective recombinant vesicular stomatitis virus is more potent than one based on a replication-competent vector","volume":"376","author":"Kapadia","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.omtn.2026.102852_bib25","doi-asserted-by":"crossref","first-page":"6993","DOI":"10.1128\/JVI.00365-06","article-title":"Evaluating replication-defective vesicular stomatitis virus as a vaccine vehicle","volume":"80","author":"Majid","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2026.102852_bib26","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1172\/JCI78280","article-title":"Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling","volume":"125","author":"Quinn","year":"2015","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omtn.2026.102852_bib27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1128\/JVI.01597-10","article-title":"Multiple innate immune pathways contribute to the immunogenicity of recombinant adenovirus vaccine vectors","volume":"85","author":"Rhee","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2026.102852_bib28","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.4049\/jimmunol.1400197","article-title":"Priming of CD8 T cells by adenoviral vectors is critically dependent on B7 and dendritic cells but only partially dependent on CD28 ligation on CD8 T cells","volume":"193","author":"Nielsen","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.omtn.2026.102852_bib29","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/s42003-021-02251-6","article-title":"Lentiviral vector induces high-quality memory T cells via dendritic cells transduction","volume":"4","author":"Ku","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.omtn.2026.102852_bib30","doi-asserted-by":"crossref","first-page":"12027","DOI":"10.1128\/JVI.00593-09","article-title":"Persistence of transgene expression influences CD8+ T-cell expansion and maintenance following immunization with recombinant adenovirus","volume":"83","author":"Finn","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2026.102852_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073511","article-title":"A novel naturally occurring tandem promoter in modified vaccinia virus ankara drives very early gene expression and potent immune responses","volume":"8","author":"Wennier","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2026.102852_bib32","doi-asserted-by":"crossref","first-page":"8743","DOI":"10.1128\/JVI.00604-10","article-title":"Immediate-early expression of a recombinant antigen by modified vaccinia virus ankara breaks the immunodominance of strong vector-specific B8R antigen in acute and memory CD8 T-cell responses","volume":"84","author":"Baur","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2026.102852_bib33","doi-asserted-by":"crossref","first-page":"581","DOI":"10.3390\/vaccines2030581","article-title":"Gene Expression Driven by a Strong Viral Promoter in MVA Increases Vaccination Efficiency by Enhancing Antibody Responses and Unmasking CD8(+) T Cell Epitopes","volume":"2","author":"Becker","year":"2014","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.omtn.2026.102852_bib34","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191220","article-title":"Early type I IFN blockade improves the efficacy of viral vaccines","volume":"217","author":"Palacio","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.omtn.2026.102852_bib35","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1002\/eji.201040453","article-title":"Concomitant type I IFN receptor-triggering of T cells and of DC is required to promote maximal modified vaccinia virus Ankara-induced T-cell expansion","volume":"40","author":"Frenz","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.omtn.2026.102852_bib36","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00925-21","article-title":"Type I Interferon Promotes Humoral Immunity in Viral Vector Vaccination","volume":"95","author":"Zhong","year":"2021","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2026.102852_bib37","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1128\/JVI.01617-08","article-title":"Vaccinia virus-mediated inhibition of type I interferon responses is a multifactorial process involving the soluble type I interferon receptor B18 and intracellular components","volume":"83","author":"Waibler","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2026.102852_bib38","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.virol.2017.12.016","article-title":"Inhibition of type I interferon responses by adenovirus serotype-dependent Gas6 binding","volume":"515","author":"Nidetz","year":"2018","journal-title":"Virology"},{"key":"10.1016\/j.omtn.2026.102852_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003989","article-title":"Modified vaccinia virus Ankara triggers type I IFN production in murine conventional dendritic cells via a cGAS\/STING-mediated cytosolic DNA-sensing pathway","volume":"10","author":"Dai","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.omtn.2026.102852_bib40","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41467-017-02624-8","article-title":"Human cytomegalovirus-encoded US9 targets MAVS and STING signaling to evade type I interferon immune responses","volume":"9","author":"Choi","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.102852_bib41","doi-asserted-by":"crossref","first-page":"6259","DOI":"10.1128\/JVI.00084-06","article-title":"Immunogenicity of cytopathic and noncytopathic viral vectors","volume":"80","author":"Plesa","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2026.102852_bib42","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nri1783","article-title":"Antiviral antibody responses: the two extremes of a wide spectrum","volume":"6","author":"Hangartner","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.omtn.2026.102852_bib43","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/0042-6822(82)90126-X","article-title":"The interaction of antibody with the major surface glycoprotein of vesicular stomatitis virus. II. Monoclonal antibodies of nonneutralizing and cross-reactive epitopes of Indiana and New Jersey serotypes","volume":"121","author":"Lefrancois","year":"1982","journal-title":"Virology"},{"key":"10.1016\/j.omtn.2026.102852_bib44","first-page":"175","article-title":"The role of antibodies in natural and acquired resistance of mice to vesicular stomatitis virus","volume":"56","author":"Gobet","year":"1988","journal-title":"Exp. Cell Biol."},{"key":"10.1016\/j.omtn.2026.102852_bib45","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/345068a0","article-title":"Virus-induced autoantibody response to a transgenic viral antigen","volume":"345","author":"Zinkernagel","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.102852_bib46","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1172\/JCI200422374","article-title":"Kinetics of protective antibodies are determined by the viral surface antigen","volume":"114","author":"Pinschewer","year":"2004","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omtn.2026.102852_bib47","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0140-6736(15)61117-5","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial","volume":"386","author":"Henao-Restrepo","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.omtn.2026.102852_bib48","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI131958","article-title":"Quadrivalent VesiculoVax vaccine protects nonhuman primates from viral-induced hemorrhagic fever and death","volume":"130","author":"Cross","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omtn.2026.102852_bib49","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/tmi.13876","article-title":"Lassa fever vaccine candidates: A scoping review of vaccine clinical trials","volume":"28","author":"Sulis","year":"2023","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.omtn.2026.102852_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0020183","article-title":"Development of a new vaccine for the prevention of Lassa fever","volume":"2","author":"Geisbert","year":"2005","journal-title":"PLoS Med."},{"key":"10.1016\/j.omtn.2026.102852_bib51","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1073\/pnas.1209591110","article-title":"Antibodies are necessary for rVSV\/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates","volume":"110","author":"Marzi","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2026.102852_bib52","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1126\/science.276.5320.1845","article-title":"Inhibition of Ran guanosine triphosphatase-dependent nuclear transport by the matrix protein of vesicular stomatitis virus","volume":"276","author":"Her","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.omtn.2026.102852_bib53","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S1097-2765(00)00120-9","article-title":"Vesicular stomatitis virus matrix protein inhibits host cell gene expression by targeting the nucleoporin Nup98","volume":"6","author":"von Kobbe","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omtn.2026.102852_bib54","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.molcel.2004.11.023","article-title":"VSV disrupts the Rae1\/mrnp41 mRNA nuclear export pathway","volume":"17","author":"Faria","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omtn.2026.102852_bib55","doi-asserted-by":"crossref","first-page":"5524","DOI":"10.1128\/JVI.77.9.5524-5528.2003","article-title":"The cell-rounding activity of the vesicular stomatitis virus matrix protein is due to the induction of cell death","volume":"77","author":"Kopecky","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2026.102852_bib56","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1128\/JVI.79.7.4170-4179.2005","article-title":"Vesicular stomatitis viruses expressing wild-type or mutant M proteins activate apoptosis through distinct pathways","volume":"79","author":"Gaddy","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2026.102852_bib57","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41416-019-0574-7","article-title":"The lytic activity of VSV-GP treatment dominates the therapeutic effects in a syngeneic model of lung cancer","volume":"121","author":"Schreiber","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.omtn.2026.102852_bib58","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/mt.2013.249","article-title":"Maraba virus as a potent oncolytic vaccine vector","volume":"22","author":"Pol","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2026.102852_bib59","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1128\/JVI.77.8.4646-4657.2003","article-title":"Ability of the matrix protein of vesicular stomatitis virus to suppress beta interferon gene expression is genetically correlated with the inhibition of host RNA and protein synthesis","volume":"77","author":"Ahmed","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2026.102852_bib60","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1099\/vir.0.80788-0","article-title":"Use of influenza C virus glycoprotein HEF for generation of vesicular stomatitis virus pseudotypes","volume":"86","author":"Hanika","year":"2005","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.omtn.2026.102852_bib61","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abi8635","article-title":"Fractionating a COVID-19 Ad5-vectored vaccine improves virus-specific immunity","volume":"6","author":"Sanchez","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.omtn.2026.102852_bib62","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1006\/smim.2000.0253","article-title":"Localization dose and time of antigens determine immune reactivity","volume":"12","author":"Zinkernagel","year":"2000","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.omtn.2026.102852_bib63","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1099\/vir.0.023978-0","article-title":"Fusion-active glycoprotein G mediates the cytotoxicity of vesicular stomatitis virus M mutants lacking host shut-off activity","volume":"91","author":"Hoffmann","year":"2010","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.omtn.2026.102852_bib64","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.4049\/jimmunol.1003783","article-title":"Combining liver- and blood-stage malaria viral-vectored vaccines: investigating mechanisms of CD8+ T cell interference","volume":"187","author":"Forbes","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.omtn.2026.102852_bib65","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/B978-0-12-394590-7.00005-1","article-title":"Probing CD8 T cell responses with Listeria monocytogenes infection","volume":"113","author":"Condotta","year":"2012","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.omtn.2026.102852_bib66","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.immuni.2013.05.009","article-title":"Effector-like CD8(+) T cells in the memory population mediate potent protective immunity","volume":"38","author":"Olson","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.omtn.2026.102852_bib67","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210116","article-title":"Sphingosine 1-phosphate receptor 5 (S1PR5) regulates the peripheral retention of tissue-resident lymphocytes","volume":"219","author":"Evrard","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.omtn.2026.102852_bib68","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1084\/jem.20150194","article-title":"Transcriptional repressor ZEB2 promotes terminal differentiation of CD8+ effector and memory T cell populations during infection","volume":"212","author":"Omilusik","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.omtn.2026.102852_bib69","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15327","article-title":"Replicating viral vector platform exploits alarmin signals for potent CD8(+) T cell-mediated tumour immunotherapy","volume":"8","author":"Kallert","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.102852_bib70","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.virol.2020.06.013","article-title":"The VSV matrix protein inhibits NF-kappaB and the interferon response independently in mouse L929 cells","volume":"548","author":"Marquis","year":"2020","journal-title":"Virology"},{"key":"10.1016\/j.omtn.2026.102852_bib71","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1089\/jir.2009.0068","article-title":"Rhabdovirus evasion of the interferon system","volume":"29","author":"Rieder","year":"2009","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.omtn.2026.102852_bib72","doi-asserted-by":"crossref","first-page":"8185","DOI":"10.1128\/JVI.07240-11","article-title":"Arenavirus nucleoproteins prevent activation of nuclear factor kappa B","volume":"86","author":"Rodrigo","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2026.102852_bib73","doi-asserted-by":"crossref","first-page":"7728","DOI":"10.1128\/JVI.00187-12","article-title":"Arenavirus nucleoprotein targets interferon regulatory factor-activating kinase IKKepsilon","volume":"86","author":"Pythoud","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2026.102852_bib74","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1002\/eji.200839093","article-title":"Effector T-cell differentiation during viral and bacterial infections: Role of direct IL-12 signals for cell fate decision of CD8(+) T cells","volume":"39","author":"Keppler","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.omtn.2026.102852_bib75","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.immuni.2014.05.003","article-title":"Type I interferons protect T cells against NK cell attack mediated by the activating receptor NCR1","volume":"40","author":"Crouse","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.omtn.2026.102852_bib76","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.immuni.2014.05.004","article-title":"Type I interferon protects antiviral CD8+ T cells from NK cell cytotoxicity","volume":"40","author":"Xu","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.omtn.2026.102852_bib77","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.immuni.2006.08.014","article-title":"Complex modulation of cell type-specific signaling in response to type I interferons","volume":"25","author":"van Boxel-Dezaire","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.omtn.2026.102852_bib78","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20241148","article-title":"Transient inhibition of type I interferon enhances CD8+ T cell stemness and vaccine protection","volume":"222","author":"Broomfield","year":"2025","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.omtn.2026.102852_bib79","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1084\/jem.20050821","article-title":"Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection","volume":"202","author":"Kolumam","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.omtn.2026.102852_bib80","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1084\/jem.20130901","article-title":"IL-12 and type I interferon prolong the division of activated CD8 T cells by maintaining high-affinity IL-2 signaling in vivo","volume":"211","author":"Starbeck-Miller","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.omtn.2026.102852_bib81","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/eji.201142091","article-title":"Type-I IFN drives the differentiation of short-lived effector CD8+ T cells in vivo","volume":"42","author":"Wiesel","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.omtn.2026.102852_bib82","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.4049\/jimmunol.177.3.1746","article-title":"Innate inflammatory signals induced by various pathogens differentially dictate the IFN-I dependence of CD8 T cells for clonal expansion and memory formation","volume":"177","author":"Thompson","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.omtn.2026.102852_bib83","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1002\/eji.201141537","article-title":"Signal 3 requirement for memory CD8+ T-cell activation is determined by the infectious pathogen","volume":"41","author":"Keppler","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.omtn.2026.102852_bib84","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1126\/science.1132998","article-title":"RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates","volume":"314","author":"Pichlmair","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.omtn.2026.102852_bib85","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1959140","article-title":"Differential infection of murine and human dendritic cell subsets by oncolytic vesicular stomatitis virus variants","volume":"10","author":"Pipperger","year":"2021","journal-title":"OncoImmunology"},{"key":"10.1016\/j.omtn.2026.102852_bib86","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131137","article-title":"Impact of Vesicular Stomatitis Virus M Proteins on Different Cellular Functions","volume":"10","author":"Redondo","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2026.102852_bib87","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1535-6108(03)00241-1","article-title":"VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents","volume":"4","author":"Stojdl","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omtn.2026.102852_bib88","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aah6817","article-title":"Interferon-driven deletion of antiviral B cells at the onset of chronic infection","volume":"1","author":"Fallet","year":"2016","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.omtn.2026.102852_bib89","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aah6789","article-title":"Inflammatory monocytes hinder antiviral B cell responses","volume":"1","author":"Sammicheli","year":"2016","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.omtn.2026.102852_bib90","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aah3565","article-title":"Type I interferon suppresses virus-specific B cell responses by modulating CD8(+) T cell differentiation","volume":"1","author":"Moseman","year":"2016","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.omtn.2026.102852_bib91","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3389\/fimmu.2020.00909","article-title":"Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines","volume":"11","author":"Coughlan","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtn.2026.102852_bib92","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1126\/science.282.5396.2079","article-title":"Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus","volume":"282","author":"Cao","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.omtn.2026.102852_bib93","doi-asserted-by":"crossref","first-page":"7306","DOI":"10.1073\/pnas.1214441110","article-title":"LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus","volume":"110","author":"Finkelshtein","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2026.102852_bib94","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.1128\/JVI.03276-13","article-title":"VSV-GP: a potent viral vaccine vector that boosts the immune response upon repeated applications","volume":"88","author":"Tober","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2026.102852_bib95","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1093\/infdis\/jiaa121","article-title":"A Randomized Dose-Escalating Phase I Trial of a Replication-Deficient Lymphocytic Choriomeningitis Virus Vector-Based Vaccine Against Human Cytomegalovirus","volume":"225","author":"Schwendinger","year":"2022","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.omtn.2026.102852_bib96","doi-asserted-by":"crossref","first-page":"965","DOI":"10.4049\/jimmunol.162.2.965","article-title":"IL-12 is not required for induction of type 1 cytokine responses in viral infections","volume":"162","author":"Oxenius","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.omtn.2026.102852_bib97","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.immuni.2009.11.010","article-title":"Prolonged interleukin-2Ralpha expression on virus-specific CD8+ T cells favors terminal-effector differentiation in vivo","volume":"32","author":"Kalia","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.omtn.2026.102852_bib98","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.1128\/JVI.73.6.4748-4754.1999","article-title":"Role of the individual interferon systems and specific immunity in mice in controlling systemic dissemination of attenuated pseudorabies virus infection","volume":"73","author":"Grob","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2026.102852_bib99","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1126\/science.8009221","article-title":"Functional role of type I and type II interferons in antiviral defense","volume":"264","author":"Muller","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.omtn.2026.102852_bib100","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0092-8674(94)90169-4","article-title":"T cell receptor antagonist peptides induce positive selection","volume":"76","author":"Hogquist","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2026.102852_bib101","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1073\/pnas.0600652103","article-title":"Recovery of an arenavirus entirely from RNA polymerase I\/II-driven cDNA","volume":"103","author":"Flatz","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2026.102852_bib102","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0166-0934(91)90018-U","article-title":"Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates","volume":"33","author":"Battegay","year":"1991","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.omtn.2026.102852_bib103","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.4049\/jimmunol.136.8.3057","article-title":"Antibody mediated suppression of secondary IgM response in nude mice against vesicular stomatitis virus","volume":"136","author":"Charan","year":"1986","journal-title":"J. Immunol."},{"key":"10.1016\/j.omtn.2026.102852_bib104","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.4049\/jimmunol.166.5.3402","article-title":"Organ-specific regulation of the CD8 T cell response to Listeria monocytogenes infection","volume":"166","author":"Pope","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.omtn.2026.102852_bib105","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omtn.2026.102852_bib106","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13059-019-1662-y","article-title":"EmptyDrops: distinguishing cells from empty droplets in droplet-based single-cell RNA sequencing data","volume":"20","author":"Lun","year":"2019","journal-title":"Genome Biol."},{"key":"10.1016\/j.omtn.2026.102852_bib107","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaf018","article-title":"edgeR v4: powerful differential analysis of sequencing data with expanded functionality and improved support for small counts and larger datasets","volume":"53","author":"Chen","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.102852_bib108","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nbt.4091","article-title":"Batch effects in single-cell RNA-sequencing data are corrected by matching mutual nearest neighbors","volume":"36","author":"Haghverdi","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2026.102852_bib109","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13059-021-02581-y","article-title":"Universal prediction of cell-cycle position using transfer learning","volume":"23","author":"Zheng","year":"2022","journal-title":"Genome Biol."},{"key":"10.1016\/j.omtn.2026.102852_bib110","first-page":"2122","article-title":"A step-by-step workflow for low-level analysis of single-cell RNA-seq data with Bioconductor","volume":"5","author":"Lun","year":"2016","journal-title":"F1000Res."},{"key":"10.1016\/j.omtn.2026.102852_bib111","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/bioinformatics\/btw777","article-title":"Scater: pre-processing, quality control, normalization and visualization of single-cell RNA-seq data in R","volume":"33","author":"McCarthy","year":"2017","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omtn.2026.102852_bib112","series-title":"Igraph for R: R Interface of the Igraph Library for Graph Theory and Network Analysis (v2.1.1)","author":"Cs\u00e1rdi","year":"2024"},{"key":"10.1016\/j.omtn.2026.102852_bib113","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.102852_bib114","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.immuni.2023.01.029","article-title":"The alarmin interleukin-33 promotes the expansion and preserves the stemness of Tcf-1(+) CD8(+) T cells in chronic viral infection","volume":"56","author":"Marx","year":"2023","journal-title":"Immunity"}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126000235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126000235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T20:00:20Z","timestamp":1784232020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253126000235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":114,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2162253126000235"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2026.102852","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.11.04.685127","asserted-by":"object"}]},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-cytolytic re-engineering of a viral vaccine vector enables durable effector-memory T cell immunity by reinforcing type I IFN induction","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2026.102852","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102852"}}